Background Although non-alcoholic fatty liver disease (NAFLD) is commonly associated
with obesity, it is increasingly being identified in non-obese individuals. We aimed to …

Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver
disease in the Western world, probably due to the growing prevalence of obesity, metabolic …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide and
parallels comorbidities such as obesity, metabolic syndrome, dyslipidemia, and diabetes …

Data on prevalence and profile of nonalcoholic fatty liver disease (NAFLD) among
individuals who are lean (normal body mass index) is unclear. Published data from studies …

Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …

Non-alcoholic fatty liver disease (NAFLD) in children and adolescents has an estimated
prevalence of 36.1% in the context of obesity. This figure is anticipated to increase in …

The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing over the
years and is now as high in Asia as in the Western world, so much so that it should no longer …

Lean NAFLD is a special phenotypic closely correlated with metabolic syndrome (MS). The
aim of this study is to investigate the MS development and the gender differences in lean …

Background There is a wide variation across studies in the reported prevalence of
nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). A …

Background Low-density lipoprotein to high density lipoprotein (LDL/HDL) cholesterol ratio
has been reported to predict the risk of many metabolic diseases. However, the association …